Eli Lilly's jet returns to Indianapolis amid $4.5 billion manufacturing expansion

Eli Lilly and Company sent its Gulfstream G500, registration N308EL, airborne from Toronto Pearson International Airport at 10:11 p.m. on May 7, 2026, touching down at Indianapolis International—its home base—78 minutes later. The efficient crossing hit 40,000 feet and a brisk 467 knots, par for the course in executive travel for the GLP-1 trailblazer.

The arrival coincides with a pivotal moment for Eli Lilly in Indiana, as the company unveiled an extra $4.5 billion commitment to its manufacturing network and inaugurated its inaugural dedicated genetic medicine facility, according to a May 6 announcement covered by Reuters. Joined by Governor Mike Braun for the Lebanon site event, this expansion cements the Hoosier State's biotech edge—just what a firm riding high on Mounjaro and Zepbound needs to keep the momentum.

This return caps a hectic May 6 itinerary for the fleet, with hops linking Indianapolis to Kansas City, Denver, and Toronto, hinting at cross-border strategizing. Against recurring jaunts to hubs like Washington and London, such flurries underscore Eli Lilly's globe-trotting grind in pursuit of pharmaceutical primacy.